Participant Information
What is the SAVE study?
SAVE is an international study, attempting to discover if the use of CPAP can reduce the risk of heart attack, stroke or heart failure in patients with OSA.
If you meet the entry requirements and agree to take part in SAVE you will be screened for OSA using a simple overnight diagnostic device in your own home. If the results of this test indicate you have OSA, the study will be explained to you in greater detail by your treating clinician or study nurse, and you will be invited to enroll into the main phase of the study.
In the study's main phase, we will be evaluating the effects of CPAP on cardiovascular disease. You will be randomly allocated (like the toss of a coin) to either receive treatment with CPAP, or to continue with your usual medical care.
You will receive follow up from hospital staff for the next four (4) years, evaluating your health and the impact of the OSA treatment. The results may lead to a new medical approach to the treatment of heart attacks and strokes.
